Currently, there is an ongoing randomised double-masked placebo-controlled trial, the SUMMIT trial, studying the efficacy and safety of tirzepatide, a dual agonist of glucose-dependent insulinotropic polypeptide and GLP-1 receptors, versus placebo in HFpEF patients with obesity (NCT04847557)
Gureev AP, Nesterova VV, Babenkova PI, Ivanov ME, Plotnikov EY, Silachev DN (2025) L-carnitine and mildronate demonstrate divergent protective effects on mitochondrial DNA quality control and inflammation following traumatic brain injury
[0021] Another important aspect of the present invention is to further improve paracellular transport of semaglutide across nasal mucosa by tight junction modulating agents
Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management
PubMed Central , Genetics and Molecular Research: GMR , vol
For those who qualify, the Lilly Cares Foundation Patient Assistance Program (PAP) offers free medication
